Alkaloid AD Skopje (XMAE:ALK) Beneish M-Score: -2.01 (As of Jun. 26, 2026)


XMAE:ALK Alkaloid AD Skopje XMAE:ALK
100 GF Score
Price MKD24,300.00
GF Value MKD27,166.15
Valuation Modestly Undervalued
View Full Analysis

What is Alkaloid AD Skopje Beneish M-Score?

Alkaloid AD Skopje XMAE:ALK +0.21% 100 Beneish M-Score is -2.01 as of Jun. 26, 2026. GuruFocus rates XMAE:ALK with a GF Score™ of 100/100 and a GF Value™ of MKD27,166.15 (Modestly Undervalued). Among 911 Drug Manufacturers companies, Alkaloid AD Skopje ranks worse than 78.16% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.01 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Alkaloid AD Skopje's Beneish M-Score or its related term are showing as below:

XMAE:ALK' s Beneish M-Score Range Over the Past 10 Years
Min: -2.83   Med: -2.15   Max: -2.01
Current: -2.01

During the past 13 years, the highest Beneish M-Score of Alkaloid AD Skopje was -2.01. The lowest was -2.83. And the median was -2.15.


Alkaloid AD Skopje Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Alkaloid AD Skopje's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkaloid AD Skopje Beneish M-Score Chart

Alkaloid AD Skopje Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.67 -2.37 -2.52 -2.30 -2.01

Alkaloid AD Skopje Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.01 0.00

XMAE:ALK vs ZTS, UTHR, VTRS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkaloid AD Skopje Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Alkaloid AD Skopje's Beneish M-Score falls into.


XMAE:ALK
100GF Score
Alkaloid AD Skopje XMAE:ALK
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkaloid AD Skopje Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Alkaloid AD Skopje for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3648+0.528 * 1.0062+0.404 * 0.9363+0.892 * 1.0996+0.115 * 0.8315
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0108+4.679 * 0.023214-0.327 * 1.0573
=-2.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was MKD5,433 Mil.
Revenue was MKD20,899 Mil.
Gross Profit was MKD9,412 Mil.
Total Current Assets was MKD12,418 Mil.
Total Assets was MKD24,355 Mil.
Property, Plant and Equipment(Net PPE) was MKD9,087 Mil.
Depreciation, Depletion and Amortization(DDA) was MKD1,371 Mil.
Selling, General, & Admin. Expense(SGA) was MKD7,088 Mil.
Total Current Liabilities was MKD7,060 Mil.
Long-Term Debt & Capital Lease Obligation was MKD981 Mil.
Net Income was MKD1,796 Mil.
Gross Profit was MKD0 Mil.
Cash Flow from Operations was MKD1,230 Mil.
Total Receivables was MKD3,620 Mil.
Revenue was MKD19,006 Mil.
Gross Profit was MKD8,612 Mil.
Total Current Assets was MKD10,537 Mil.
Total Assets was MKD21,471 Mil.
Property, Plant and Equipment(Net PPE) was MKD8,251 Mil.
Depreciation, Depletion and Amortization(DDA) was MKD1,009 Mil.
Selling, General, & Admin. Expense(SGA) was MKD6,377 Mil.
Total Current Liabilities was MKD5,966 Mil.
Long-Term Debt & Capital Lease Obligation was MKD739 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5432.685 / 20899.116) / (3619.884 / 19005.696)
=0.259948 / 0.190463
=1.3648

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8612.307 / 19005.696) / (9411.997 / 20899.116)
=0.453143 / 0.450354
=1.0062

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (12417.61 + 9086.737) / 24354.919) / (1 - (10536.699 + 8250.537) / 21471.232)
=0.117043 / 0.125004
=0.9363

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=20899.116 / 19005.696
=1.0996

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1009.236 / (1009.236 + 8250.537)) / (1370.774 / (1370.774 + 9086.737))
=0.108991 / 0.13108
=0.8315

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(7087.877 / 20899.116) / (6376.554 / 19005.696)
=0.339147 / 0.335508
=1.0108

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((981.079 + 7060.116) / 24354.919) / ((739.023 + 5965.591) / 21471.232)
=0.330167 / 0.31226
=1.0573

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1795.766 - 0 - 1230.386) / 24354.919
=0.023214

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Alkaloid AD Skopje has a M-score of -2.01 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.01 mean?
Alkaloid AD Skopje (XMAE:ALK) has a Beneish M-Score of -2.01 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Alkaloid AD Skopje and its competitors. According to the industry distribution chart, Alkaloid AD Skopje ranks #712 out of 911 companies in the Drug Manufacturers industry, placing it in the top 78.2%.
Is Alkaloid AD Skopje's Beneish M-Score too high?
Alkaloid AD Skopje's current Beneish M-Score is -2.01. Based on the distribution chart, Alkaloid AD Skopje ranks #712 out of 911 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Alkaloid AD Skopje has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkaloid AD Skopje's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Alkaloid AD Skopje ranks #712 out of 911 companies for Beneish M-Score. This places Alkaloid AD Skopje in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Alkaloid AD Skopje and its competitors. Alkaloid AD Skopje's current Beneish M-Score is -2.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkaloid AD Skopje stock overvalued right now?
Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,166.15, compared to a current price of MKD24,300.00 — trading 10.6% below its estimated fair value. The current Beneish M-Score is -2.01. Alkaloid AD Skopje's overall GF Score™ is 100/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current Beneish M-Score is -2.01 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?

Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued. The current stock price of MKD24,300.00 is trading 10.6% below its estimated GF Value™ of MKD27,166.15. GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.

Key valuation signals for XMAE:ALK:

  • Beneish M-Score: -2.01
  • GF Value™: MKD27,166.15 vs. price of MKD24,300.00 (10.6% below fair value)
  • GF Score™: 100/100

No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alkaloid AD Skopje Business Description

Address Boulevard Aleksandar, Makedonski 12, Skopje, MKD, 1000
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
100GF Score

Get the complete analysis for XMAE:ALK

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MKD24,300.00
Price
MKD27,166.15
GF Value